← FDA DRUG APPROVALS

FDA ANDA · ANDA086595

PREDNISONE

Sponsor: MUTUAL PHARM

APPLICATION
ANDA086595
TYPE
ANDA
ORIGINAL APPROVAL
1979-04-10
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PREDNISONEDiscontinued
PREDNISONE 10MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 35AP
1995-04-05Labeling · Supplement 32AP
1994-12-23Manufacturing (CMC) · Supplement 34AP
1994-12-12Labeling · Supplement 27AP
1994-12-12Manufacturing (CMC) · Supplement 25AP
1994-12-12Manufacturing (CMC) · Supplement 26AP
1994-12-12Manufacturing (CMC) · Supplement 24AP
1994-10-11Manufacturing (CMC) · Supplement 33AP
1992-04-03Manufacturing (CMC) · Supplement 29AP
1991-02-19Labeling · Supplement 28AP
1987-04-01Manufacturing (CMC) · Supplement 22AP
1986-01-17Manufacturing (CMC) · Supplement 17AP
1986-01-17Manufacturing (CMC) · Supplement 15AP
1986-01-17Manufacturing (CMC) · Supplement 16AP
1979-04-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →